Zwolle, Netherlands

Ferdinand Jacobus Milder

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.3

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Ferdinand Jacobus Milder

Introduction

Ferdinand Jacobus Milder is a notable inventor based in Zwolle, Netherlands. He has made significant contributions to the field of vaccine development, particularly in relation to influenza virus vaccines. With a total of three patents to his name, Milder's work is crucial in the ongoing fight against viral infections.

Latest Patents

Milder's latest patents focus on influenza virus vaccines and their applications. One of his patents details group 2 influenza hemagglutinin stem polypeptides, along with nucleic acids encoding these polypeptides. This patent also includes vectors comprising the nucleic acid and pharmaceutical compositions that utilize these innovations. The methods outlined in his patents are particularly aimed at the prevention and treatment of influenza virus infections.

Career Highlights

Ferdinand Jacobus Milder is currently associated with Janssen Vaccines & Prevention B.V., where he continues to advance his research in vaccine technology. His work is instrumental in developing effective strategies to combat influenza, a virus that poses significant health risks globally.

Collaborations

Milder collaborates with esteemed colleagues such as Tina Ritschel and Boerries Brandenburg. Their combined expertise enhances the research and development efforts at Janssen Vaccines & Prevention B.V.

Conclusion

Ferdinand Jacobus Milder's contributions to vaccine development, particularly in influenza, highlight his importance as an inventor in the medical field. His innovative patents and collaborations are paving the way for advancements in public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…